Alnylam Pharmaceuticals authorizes $1B share repurchase program
FROM THE WIRE · SEEKINGALPHA.COM
* Alnylam Pharmaceuticals (ALNY [https://seekingalpha.com/symbol/ALNY]) announced [https://seekingalpha.com/pr/20714113-alnylam-announces-1-billion-share-repurchase-program-and-change-in-commercial-leadership] that its board has authorized a $1B share repurchase program. * The…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA buyback of this size can support the stock, with about $500M planned by end of 2026.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01The board authorized a $1 billion share repurchase program.
- 02The company expects to repurchase about $500M of shares by the end of 2026.
- 03The remaining $500M is planned for 2027.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets